400 billion yuan is enough to complete the entire clinical trial. Before the money is used up, the new drug will definitely be launched on the market and profitable.

So Chen Xuan will definitely not be short of money.

"The big four banks don't do this for no reason."

"The 400 billion interest-free loan must have been ordered by Hua Xia."

"But this isn't surprising. Antai Pharmaceutical Group is so dazzling that China will definitely support it."

Anna also quickly thought of this.

Banking is an industry that only does business if there is profit.

How could a bank possibly touch such a thing that has no profit?

Unless it is a task assigned by Hua Xia himself, it is possible that the bank will not even take the benefits.

After all, the four major banks are state-owned banks, which are different from private banks. They must follow the instructions of the state.

"It seems that China is also expressing its attitude by doing this."

"We want outside investors to know that Antai Pharmaceutical Group is not something they can get involved in."

"Therefore, we at Novartis basically have no hope of raising funds. At best, we can only cooperate, and as for other capital, it is even more impossible."

After sorting out everything, Anna looked regretful.

It seemed as if a large number of opportunities had slipped away from her.

“Pfizer was shorted this time.”

"I wonder if it has anything to do with Chen Xuan?"

"I heard that the short position this time exceeded 20 billion US dollars. Could it be his handiwork?"

Anna also thought about this again.

She asked someone to keep an eye on Pfizer's movements, hoping to do a favor for Chen Xuan.

As a result, we didn't hear any news from Pfizer, but instead discovered that Pfizer was being shorted.

Pfizer has been shorted on a large scale, with the current short position exceeding US$200 billion, making it the largest short position at present.

Short selling at the tens of billions level is still very rare. It usually only occurs in giants such as fruit companies and Tesla. It is relatively rare for pharmaceutical companies to be shorted on such a large scale.

In particular, Pfizer's market value is only about 200 billion US dollars, and the short position has now reached 20 billion US dollars, which is equivalent to 1/10 of its market value.

Even giants like Apple and Tesla, which are often shorted, have never experienced this situation.

That's why Anna was very surprised.

This news also caused turmoil in the entire financial market. They all wanted to know who was short selling.

It is naturally impossible for a $200 billion short sale to come from one person, but everyone knows that the bulk of it must come from one person or one company.

As for who this person is and why he shorted Pfizer, that is a mystery.

For Anna, the first person she thought of was Chen Xuan.

Although, she didn't know why she thought of him, she just felt that he was the most likely one.

"I remember him shorting his opponent before."

"It seems to be the Dasheng Pharmaceutical Group. He seemed to have made hundreds of billions, but this group also went bankrupt."

"If the company being shorted this time is Pfizer, what kind of trump card has he prepared? Will Pfizer also be doomed like Dasheng Pharmaceutical Group?"

Anna suddenly remembered the past.

She still has a vivid memory of the short selling of Dasheng Pharmaceutical Group.

This move is exactly the same as the previous short-selling of Dasheng Pharmaceutical Group, so she thought of Chen Xuan first.

And now, she is also very much looking forward to his trump card.

She would naturally be happy if it could bring bad luck to Pfizer.

Pfizer is also a competitor of Novartis.

The more unlucky the opponent is, the greater the profit will be.

But An Yi was more looking forward to Chen Xuan's move. She really wanted to know what killer move he had prepared to short Pfizer.

……

……

“We’ve been shorted?”

"Two hundred billion US dollars? Who did this?"

Tap the screen to use advanced tools Tip: You can use left and right keyboard keys to browse between chapters.

You'll Also Like